Back

Indexes of anticoagulation control and major adverse outcomes in patients with atrial fibrillation: an analysis from the AFFIRM Trial

19 March 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 3 - Atrial Fibrillation - Stroke Prevention Oral Anticoagulation EHRA Premium Access EHRA 2019

About the speaker

Photo
Associate Professor Marco Proietti

University of Milan, Milan (Italy)

8 More presentations in this session

Presentation thumbnail
Associate Professor M. Proietti (Milan, IT)
Abstract Slides
Presentation thumbnail
Doctor B. Slavchev (Sofia, BG)
Abstract Slides
Presentation thumbnail
Doctor A. Bodin (Chambray Les Tours, FR)
Abstract
Presentation thumbnail
Doctor C. Tomasi (Ravenna, IT)
Abstract
Presentation thumbnail
Professor J. Camm (London, GB)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Atrial Fibrillation - Stroke Prevention

The Event

Event poster

EHRA 2019

19 March 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Association between personalized evidence-based anticoagulation therapy and outcomes at 1-year follow-up in patients with atrial fibrillation: an analysis from the Atrial Fibrillation Registry
29 June 2021
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
17 May 2025
thumbnail
Congress Presentation
Lower dose direct oral anticoagulation and warfarin in atrial fibrillation. Ischemic stroke, intracranial hemorrhage and mortality in a nationwide registry study.
26 August 2023
thumbnail
Congress Presentation
Meta-analysis comparing the efficacy and safety of direct acting oral anticoagulants to warfarin in patients with atrial fibrillation with and without diabetes
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources